HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Catherine Creuzot-Garcher Selected Research

Cysts

1/2021EPIDEMIOLOGY OF VITREOMACULAR INTERFACE ABNORMALITIES USING MACULAR SPECTRAL-DOMAIN OPTICAL COHERENCE TOMOGRAPHY IN AN ELDERLY POPULATION (THE MONTRACHET STUDY).
1/2019Vitreomacular Interface Abnormalities and Glaucoma in an Elderly Population (The MONTRACHET Study).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Catherine Creuzot-Garcher Research Topics

Disease

14Macular Edema
11/2022 - 01/2010
14Glaucoma
07/2022 - 05/2004
13Macular Degeneration (Age-Related Maculopathy)
12/2022 - 04/2007
11Blindness (Hysterical Blindness)
12/2022 - 01/2016
11Cataract (Cataracts)
09/2022 - 03/2012
10Endophthalmitis (Ophthalmia)
01/2022 - 12/2009
9Epiretinal Membrane (Epiretinal Membranes)
01/2021 - 01/2010
8Retinal Detachment (Retinal Detachments)
11/2022 - 01/2013
7Retinal Vein Occlusion
11/2022 - 01/2016
7Dry Eye Syndromes (Dry Eye Syndrome)
05/2022 - 11/2011
7Inflammation (Inflammations)
01/2018 - 11/2002
6Diabetic Retinopathy (Retinopathy, Diabetic)
02/2022 - 01/2014
4COVID-19
06/2022 - 01/2022
3Retinal Diseases
11/2022 - 12/2018
3Open-Angle Glaucoma (Glaucoma, Open Angle)
03/2022 - 12/2009
3Vision Disorders (Hemeralopia)
01/2022 - 01/2019
3Retinal Perforations
01/2021 - 09/2010
3Acute Coronary Syndrome
10/2020 - 01/2018
3Keratitis
06/2020 - 11/2002
3Uveitis
10/2016 - 10/2012
2Genetic Risk Score
01/2022 - 01/2021
2Atrophy
11/2021 - 01/2016
2Cysts
01/2021 - 01/2019
2Hemorrhage
12/2020 - 10/2012
2Hypertension (High Blood Pressure)
01/2018 - 01/2018
2Rupture
01/2017 - 01/2016
2Toxoplasmosis
01/2015 - 10/2012
1Ocular Hypertension (Glaucoma, Suspect)
07/2022
1Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
05/2022
1Atherosclerotic Plaque (Atheroma)
05/2022
1Inborn Genetic Diseases (Disease, Hereditary)
05/2022
1White Dot Syndromes
03/2022
1Choroidal Neovascularization
02/2022
1Cardiovascular Diseases (Cardiovascular Disease)
11/2021
1Fibrosis (Cirrhosis)
11/2021
1Keratoconus
09/2021
1Edema (Dropsy)
04/2021
1Ganglion Cysts (Ganglion)
01/2021
1Giant Cell Arteritis (Horton Disease)
01/2021
1Posterior Uveitis
02/2020
1Acute Kidney Injury (Acute Renal Failure)
01/2019
1Chronic Renal Insufficiency
01/2019

Drug/Important Bio-Agent (IBA)

32Retinaldehyde (Retinal)IBA
12/2022 - 04/2007
14Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2022 - 07/2015
11Ranibizumab (Lucentis)FDA Link
12/2022 - 01/2018
7afliberceptIBA
12/2022 - 12/2018
7Dexamethasone (Maxidex)FDA LinkGeneric
04/2022 - 01/2016
624-hydroxycholesterolIBA
10/2017 - 03/2007
5CholesterolIBA
05/2022 - 04/2008
5Ophthalmic Solutions (Eye Drops)IBA
01/2019 - 11/2002
4Bevacizumab (Avastin)FDA Link
12/2022 - 01/2016
4Complement System Proteins (Complement)IBA
01/2022 - 01/2016
4CytokinesIBA
01/2018 - 12/2004
4Cholesterol 24-Hydroxylase (CYP46A1)IBA
11/2012 - 04/2007
4HLA-DR Antigens (HLA-DR)IBA
11/2011 - 11/2002
3Macular PigmentIBA
03/2022 - 11/2017
3Pharmaceutical PreparationsIBA
02/2021 - 11/2002
3LipidsIBA
01/2021 - 10/2017
3Biomarkers (Surrogate Marker)IBA
10/2020 - 02/2016
2Fatty Acids (Saturated Fatty Acids)IBA
05/2022 - 03/2021
2Antiglaucoma AgentsIBA
04/2022 - 01/2008
2insulin receptor-related receptor (IRR)IBA
05/2020 - 12/2018
2Adrenal Cortex Hormones (Corticosteroids)IBA
12/2018 - 07/2015
2Fluorescein (Funduscein)FDA LinkGeneric
01/2018 - 11/2002
2Interleukin-8 (Interleukin 8)IBA
01/2018 - 12/2004
2Cyclosporine (Ciclosporin)FDA LinkGeneric
01/2018 - 11/2016
2Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
12/2017 - 11/2017
2Biological ProductsIBA
02/2016 - 01/2015
2Anti-Bacterial Agents (Antibiotics)IBA
01/2016 - 07/2015
2InterleukinsIBA
01/2015 - 12/2004
2Interleukin-17 (Interleukin 17)IBA
01/2015 - 10/2012
2Proteins (Proteins, Gene)FDA Link
10/2012 - 10/2005
2Messenger RNA (mRNA)IBA
10/2012 - 10/2005
2Latanoprost (Xalatan)FDA Link
01/2008 - 05/2004
2Timolol (Blocadren)FDA LinkGeneric
12/2004 - 05/2004
1ChAdOx1 nCoV-19IBA
03/2022
1COVID-19 VaccinesIBA
03/2022
1Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
02/2022
1Fluocinolone Acetonide (Capex)FDA LinkGeneric
01/2021
1GlucocorticoidsIBA
01/2021
1tocilizumab (atlizumab)FDA Link
01/2021
1Fibrinolytic Agents (Antithrombotic Agents)IBA
12/2020
1Contrast MediaIBA
01/2019
1HDL LipoproteinsIBA
01/2019
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
12/2018

Therapy/Procedure

10Intravitreal Injections
12/2022 - 07/2015
7Vitrectomy
09/2022 - 12/2009
6Injections
09/2022 - 07/2015
5Therapeutics
03/2022 - 10/2012
5Traction
01/2021 - 01/2010
4Phacoemulsification
07/2022 - 03/2012
4Cataract Extraction
01/2021 - 09/2010
3Trabeculectomy (Trabeculoplasty)
06/2022 - 05/2007
3Contact Lenses
06/2020 - 07/2002
2Lasers (Laser)
06/2022 - 08/2019
2Operative Surgical Procedures
05/2020 - 01/2016
2Light Coagulation
08/2019 - 01/2018
1Vitreoretinal Surgery
01/2022
1Lenses
09/2021
1Aftercare (After-Treatment)
01/2021